Polaris Expands Ludwig Collaboration

12:26 EDT 19 May 2011 |

The San Diego-based Polaris Group has agreed to expand its collaboration with the Ludwig Institute for Cancer Research on their work together in developing pegylated arginine deiminase (ADI-PEG 20), a promising anti-cancer compound. We recently profiled the company here. Under their expanded collaboration, Polaris and the institute hope to identify other enzymes with potential anti-tumor [...]

Original Article: Polaris Expands Ludwig Collaboration


More From BioPortfolio on "Polaris Expands Ludwig Collaboration"

Quick Search


Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...